Genomics and proteomics to determine novel molecular subtypes and predict the response to immunotherapy and the effect of bevacizumab in glioblastoma
Crossref DOI link: https://doi.org/10.1038/s41598-024-68648-5
Published Online: 2024-07-31
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Luo, Dongdong
Luo, Aiping
Hu, Su
Ye, Ganwei
Li, Dan
Zhao, Hailin
Peng, Biao
Text and Data Mining valid from 2024-07-31
Version of Record valid from 2024-07-31
Article History
Received: 5 February 2024
Accepted: 25 July 2024
First Online: 31 July 2024
Competing interests
: The authors declare no competing interests.